Introduction {#Sec1}
============

In the intensive care unit (ICU) the need for acute renal replacement therapy (aRRT) is associated with high mortality and risk of end-stage renal disease (ESRD). We investigated long term mortality and progression to ESRD in ICU patients requiring aRRT and factors associated to these.

Methods {#Sec2}
=======

Retrospective analysis of all adult patients admitted to the general ICU, Rigshospitalet, from 1/1-2005 to 31/12-2012, identified through the ICU database, excluding chronic dialysis patients. ESRD was defined as the need of dialysis \>90 days or kidney transplant.

Results {#Sec3}
=======

Of 5766 patients included, 931 (16%) received aRRT, 4762 (83%) did not receive any RRT and 73 (1%) only received aRRT during a later ICU admission. The 90-day mortality was 55% for aRRT patients and 22% for those not requiring aRRT (p \< 0.001). The median (IQR) age was 61 (49 - 68) for aRRT 90-day survivors and 65 (55 - 73) for aRRT non-survivors (p \< 0.001). The median SAPS II score was 53 (43 - 64) for aRRT 90-day survivors and 61 (49 - 74) for aRRT non-survivors (p \< 0.001). Characteristics of aRRT patients developing ESRD and those that did not, are displayed in tables [1](#Tab1){ref-type="table"}-[3](#Tab3){ref-type="table"}. The 7-year risk of ESRD for patients surviving 90 days after admission was 10% (7 - 14) for aRRT patients as compared to 0.5% (95% CI 0.3-0.9) for those not receiving aRRT (p \< 0.001).Table 1Baseline characteristics.**Data available90 day survivors with ESRD (N = 38)90 day survivors without ESRD (N = 404)*P***Age (years), median (IQR)44261(52.0 - 70.0)61(49 - 68)0.400Gender (male)44225(65.8%)271(67.1%)0.999Days in the ICU, median (IQR)4427.2(3.6 - 15.6)10.9(5.7 - 20.9)0.087SAPS II score (points), median (IQR)42756(41 - 68)53(43 - 64)0.39APACHE II score (points), median (IQR)42730(25 - 35)26(21 - 31)0.009First SOFA (points), median (IQR)41711(8 - 15)12(9 - 14)0.861MAX SOFA (points), median (IQR)41812(9 - 15)13(11 - 16)0.377Vasopressor treatment44224(63.2%)297(73.5%)0.279Mechanical ventilation44230(78.9%)371(91.8%)0.040Table 2Preexisting Comorbidity.**Data available90 day survivors with ESRD (N = 38)90 day survivors without ESRD (N = 404)*P***Chronic kidney disease (non-dialysis)44223(60.5%)90(22.3%)\< 0.001Hypertension44214(36.8%)119(29.5%)0.505Diabetes4426(15.8%)56(13.9%)0.784Congestive heart failure4424(10.5%)39(9.7%)0.993Peripheral vascular disease4429(23.7%)82(20.3%)0.734Cerebrovascular disease4423(7.9%)36(8.9%)0.968Malignant neoplasm44212(31.6%)83(20.5%)0.180Ischemic heart disease4424(10.5%)29(7.2%)0.783Chronic obstructive pulmonary disease4424(10.5%)50(12.4%)0.928Table 3Primary diagnosis during ICU stay.**Data available90 day survivors with ESRD (N = 38)90 day survivors without ESRD (N = 404)*P***Sepsis4427(18.4%)112(27.7%)0.466Other infectious diseases4426(15.8%)20(5.0%)0.025Endocrinological diseases442(0.0%)3(0.7%)0.868Cardiovascular diseases4423(7.9%)43(10.6%)0.869Respiratory diseases4429(23.7%)66(16.3%)0.514Gastrointestinal or liver diseases4422(5.3%)11(2.7%)0.675Trauma or poisoning4424(10.5%)38(9.4%)0.975Other4427(18.4%)111(27.4%)0.483

Conclusions {#Sec4}
===========

The aRRT patients surviving 90 days were younger and less severely ill at ICU admission as compared to the non-survivors. The survivors developing ESRD had more frequently preexisting chronic kidney disease and higher APACHE II scores as compared to those who did not develop ESRD. aRRT patients had increased risk of ESRD up to 7 years after ICU admission, emphasizing the KDIGO recommendations to follow up AKI patients due to their increased risk for CKD.
